Dr Katharina Merollini was appointed as a Research Fellow in health economics in February 2016 and is part of the Sunshine Coast Health Institute and the School of Health and Sport Sciences. Prior to this she worked as a Post-doctoral Research Fellow at the Australian Centre for Health Services Innovation (AusHSI) at the Queensland University of Technology (QUT). She undertook her Master Degree at Friedrich-Alexander University in Germany and completed her PhD at QUT in 2011.
Katharina has a strong interest in health economic research with the ultimate goal to inform decision makers and improve health service delivery. She has conducted high quality research in multiple public health areas, such as gynaecology, orthopaedics, cardiology, infection control and epidemiology. Katharina has presented her research outcomes at international health economics conferences in Canada, Ireland and Australia and has led an international data linkage project on the cost-effectiveness of infection prevention following hip arthroplasty. She has successfully supervised PhD students and serves as a reviewer to a number of peer-reviewed journals, such as the European Journal of Cancer Care and the Australian and New Zealand Journal of Public Health.
Her current work investigates lifetime costs of surviving cancer in Queensland. Economic modeling provides an ideal platform to predict future healthcare expenditure and to show the potential impact of more investment in cancer prevention. This project is a collaboration with the Cancer Council Queensland and QIMR Berghofer Medical Research Institute. Katharina is also leading a project evaluating influenza vaccination in health care staff in collaboration with researchers at Macquarie University, the University of Queensland and QUT.
iHEA: International Health Economics Association
ISPOR-AC: International Society of Pharmacoeconomics and Outcomes Research – Australia Chapter
AHES: Australian Health Economics Society
|Investigators||Dr Katharina Merollini, A/Prof Lisa Hall, Dr Kate Halton, Prof Stephen Lambert, Dr Chisato Imai|
|Funding body||AusHSI / QUT $60,000|
|Year(s) of operation||2015-2020|
|Focus Statement||Economic evaluation of targeted flu vaccination for Queensland Health staff: clinical vs non-clinical|
HDR opportunities / Research Collaboration
Costs of Surviving Cancer – a Queensland study (COS-Q) contains linked state and national healthcare data to capture all health service utilization for up to 20 years from the date of cancer diagnosis, including hospital admissions, emergency presentations, healthcare costing data, Medicare services and pharmaceuticals. The data will be used to investigate the long-term health service use and cost of cancer survivorship on a population level in Australia. The aims of this project are:
- To quantify lifetime health service use by cancer patients from the date of diagnosis.
- To identify factors associated with high and low health service use.
- To estimate lifetime health service use and cost by cancer type from the date of diagnosis using economic modelling.
- To identify opportunities for improvement for future health service delivery.
For opportunities to use this data, collaborate or start a higher research degree, please contact Dr Katharina Merollini: firstname.lastname@example.org or A/Prof Louisa Gordon: Louisa.Gordon@qimrberghofer.edu.au.
- Financial toxicity: financial hardship faced by cancer patients
- Lifetime costs of surviving cancer in Queensland, Australia: health service usage from cancer diagnosis up to 20 years
- The cost-effectiveness of influenza vaccination for health care workers
- The cost-effectiveness of skin cancer prevention
- Presenteeism among healthcare workers with laboratory-confirmed influenza infection
- Systematic literature reviews
Dr Merollini's specialist areas of knowledge include health economics, health services research and economic evaluations